Jefferies & Company Inc.

In a company note issued earlier today, Jefferies & Company, Inc. gave a Buy rating and $12 price target to Alcoa Inc. (NYSE: AA), despite the aluminum producer's disappointing results from last quarter. Jefferies went on to say in the report “That said, the stock does appear to have found a...

Pre-open movers US stock futures are higher this morning, as investors are awaiting economic data. Futures for the Dow Jones Industrial Average surged 29 points to 13,003.00 and S&P 500 index futures rose 4.20 points to 1,367.10. Nasdaq 100 futures gained 5.50 points to 2,606.25. A Peek Into...

Jefferies & Company, Inc. has increased the price target for Textainer (NYSE: TGH) according to their research report published this morning. The price target on TGH has increased from $22.00 to $28.00. TGH had a net income of $30.6M which was $3.6M ahead of Jefferies & Co.'s estimate. Even...

Analysts Katherine Egbert and Ignatius Njoku at Jefferies & Company, Inc. have released an update on Symantec Corp. (NASDAQ: SYMC). On Thursday, the company held its analyst day in New York City. The company outlined four strategic priorities for FY11, which include continued extension of the...

Analyst Michael Dudas at Jefferies & Company Inc. has released an update on James River Coal Co. (NASDAQ: JRCC). The company reported its first-quarter results on Friday. James River reported first-quarter EPS of $0.84, which was well ahead of Jefferies’ estimate of $0.55 and consensus of $0....

Analyst Paul Fremont at Jefferies & Company Inc. has released an update on Constellation Energy Group, Inc. (NYSE: CEG). The company reported its first-quarter results, last week. Constellation reported first-quarter operating EPS of $1.43 per share, which above Jefferies’ estimate of $1.10...

Analyst Joseph Vafi at Jefferies & Company Inc. has initiated coverage of iGate Corp. (NASDAQ: IGTE) with Buy rating. The 12-month price target for iGate Corp. stock has been set at $15. Jefferies & Company says that despite solid P&L performance in the last few quarters, the company...

Analysts at Jefferies & Company Inc. have released an update on POZEN Inc. (NASDAQ: POZN). On Friday, the FDA approved the company’s Vimovo. Analysts believe that timely regulatory approval of Vimovo is a surprise as they were expecting a regulatory delay. Following the approval, analysts have...

Analyst Bruce Cranna at Jefferies & Company Inc. has released an update on Gen-Probe Incorporated (NASDAQ: GPRO). On Thursday, the company reported its first-quarter results. Gen-Probe reported first-quarter non-GAAP EPS of $0.48, beating Jefferies and consensus estimate by $0.04. First-...

Analyst Stephen Gengaro at Jefferies & Company Inc. has released an update on FMC Technologies (NYSE: FTI). The company has reported its first-quarter results. FMC Technologies reported first-quarter EPS of $0.80, which was ahead of Jefferies’ estimate of $0.67 and consensus estimate of $0.64...

Analyst George Notter at Jefferies & Company Inc. has released an update on CommScope, Inc. (NYSE: CTV). On Thursday, the company reported its first-quarter results. CommScope reported first-quarter numbers in-line with estimates. Also, the company’s revenue guidance for the second-quarter...

Analyst Michael Dudas at Jefferies & Company Inc. has released an update on Consol Energy (NYSE: CNX). The company reported its first-quarter results on Thursday. Consol Energy reported solid a first-quarter, with better met coal pricing and volumes. According to Jefferies, investor interest...

Analyst Daniel Fannon at Jefferies & Company Inc. has released an update on CME Group Inc. (NASDAQ: CME). The company reported its first-quarter results on Thursday. CME Group reported first-quarter GAAP EPS of $3.62. Following the first-quarter results, Jefferies & Company has raised its...

Analyst Laurence Alexander at Jefferies & Company Inc. has released an update on Cabot Corp. (NYSE: CBT). The company has reported its second-quarter results. Cabot reported second-quarter EPS of $0.58, which was ahead of Jefferies estimate by $0.13 and consensus by $0.14. Following the second...

Analysts Richard Close at Jefferies & Company Inc. has released an update on Athenahealth, Inc. (NASDAQ: ATHN). The company has reported its first-quarter results. Jefferies believes that Athenahealth’s first-quarter results were disappointing except for a 33% increase in revenue. Following...